| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Visiongain Report Offers Transformative Insights on the $11.8bn Anaesthesia Drugs Market
By: PR Newswire Association LLC. - 24 Apr 2019Back to overview list

Global Anaesthesia Drugs Market 2019-2029

LONDON, April 24, 2019 /PRNewswire/ -- Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others

The global anaesthesia drugs market is expected to reach $11.8bn in 2024 and is estimated to grow at a CAGR of 3.9% from 2019-2024. The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 241-page report you will receive 129 tables and 117 figures– all unavailable elsewhere.

The 241-page report provides clear detailed insight into the global anaesthesia drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at or refer to our website:

Report Scope

 Global Anaesthesia Drugs Market forecasts from 2019-2029

• Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2029 for the market segmented by type:
• Local Anaesthesia Drugs
• General Anaesthesia Drugs

• This report also provides revenue forecast to 2029 for these local anaesthesia drugs:
• Benzocaine
• Bupivacaine
• Chloroprocaine
• Lidocaine
• Prilocaine
• Ropivacaine
• Others

• This report also provides revenue forecast to 2029 for these general anaesthesia drugs:
• Desflurane
• Dexmedetomidine
• Midazolam
• Propofol
• Remifentanil
• Sevoflurane
• Others

• This report shows forecasts to 2029 for the market segmented by route of administration:
• Inhalation Anaesthesia Drugs
• Intravenous Anaesthesia Drugs
• Topical Anaesthesia Drugs

• Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
North America: US and Canada
Europe: Germany, UK, France, Italy, Spain, Rest of Europe
Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa

Each regional and national market is further segmented by type, drug and route of administration.
• This report discusses these selected leading companies:
• Baxter International, Inc.
• AbbVie
• Pfizer
• Hameln Pharmaceuticals
• AstraZeneca
• Fresenius Kabi
• Maruishi Pharmaceuticals
• Pacira Pharmaceuticals, Inc

Depending on data availability, we provide for each company: a company overview, financial information, recent development, product portfolio and a SWOT analysis.

• This report discusses promising drug candidates which are under development for the anaesthesia drugs market.

• Our study discusses trends as well as factors that drive and challenge the anaesthesia drugs market.

Visiongain's study is intended for anyone requiring commercial analyses for the anaesthesia drugs market. You find data, trends and predictions.

To request a report overview of this report please contact Sara Peerun at or refer to our website: 

Did you know that we also offer a report add-on service? Email to discuss any customized research needs you may have.

Companies covered in the report include:
AltaSelect S.r.l.
AmerisourceBergen Corporation
Aurobindo Pharma Ltd
Cardinal Health, Inc.
Fresenius Kabi
Hameln Pharmaceuticals GmbH
Hameln Pharmaceuticals Ltd.
Hameln RDS GmbH
Hospira Inc.
ICI India Ltd.
ICU Medical Inc.
Janssen Pharmaceutica NV
Jiangsu Hengrui Medicine Co.
Maruishi Pharmaceuticals
McKesson Corporation
Meda Aktiebolag
Minrad Inc.
Neon Laboratories Ltd.
Pacira Pharmaceuticals, Inc.
Piramal Critical Care Inc.
Piramal Group
Rhodia Organique Ltd.
RxElite Inc.
Sandoz International GmbH
Siegfried Group
St. Renatus LLC
Stemcentrx, Inc.

List of Other Organizations Mentioned in the Report
American Society of Aesthetic Plastic Surgery (ASAPS)
American Society of Anesthesiologists
American Society of Plastic Surgeons
Centers for Disease Control and Prevention (CDC)
European Medicines Agency (EMA)
Food and Drug Administration (FDA)
French Ministry of Health
International Narcotics Control Bureau
International Society of Aesthetic Plastic Surgery (ISAPS)
Japanese Ministry of Health, Labour and Welfare
Massachusetts General Hospital
Medicines and Healthcare Products Regulatory Agency (MHRA)
Multiple Sclerosis Foundation
National Central Cancer Registry
National Development and Reform Commission (NDRC)
United Nations Narcotics Control Bureau
United States Department of Defense
United States Department of Veterans Affairs
US Census Bureau
World Health Organization (WHO)

To see a report overview please e-mail Sara Peerun on

Related reports:

Drug Delivery Technologies Market Forecast 2019-2029                       

Global Pre-Filled Syringes Market Forecast 2019-2029             

Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2018-2028         

Global Bioreactors Market 2019-2029               

Next-Generation Biologics Market 2018-2028               

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029                     

Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018

Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018 


Copyright 2019 PR Newswire Association LLC. Back to overview list
to the top ↑